Joincare Pharmaceutical Group Industry Co.,Ltd. (SHA:600380)
China · Delayed Price · Currency is CNY 10.53
+0.04 (0.38%)
Nov 6, 2026, 3:00 PM CST
SHA:600380 Revenue
Joincare Pharmaceutical Group Industry had revenue of 3.09B CNY in the quarter ending September 30, 2026, a decrease of -13.73%. This brings the company's total for the last twelve months to 13.41B, down -11.78% year-over-year. In the year 2025, Joincare Pharmaceutical Group Industry had annual revenue of 15.22B, down -2.58%. That makes Joincare Pharmaceutical Group Industry the 4,956th largest company in the world by revenue and 649th in China.
Revenue (ttm)
13.41B
Revenue Growth
-11.78%
P/S Ratio
1.44
Revenue / Employee
987.75K
Employees
13,575
Market Cap
19.26B
Revenue by Geography
- China 12.32B 81.7%
- Overseas 2.77B 18.3%
Fiscal year ended Dec 31, 2025 See the full SHA:600380 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15.22B | -403.74M | -2.58% |
| Dec 31, 2024 | 15.62B | -1.03B | -6.17% |
| Dec 31, 2023 | 16.65B | -496.40M | -2.90% |
| Dec 31, 2022 | 17.14B | 1.24B | 7.79% |
| Dec 31, 2021 | 15.90B | 2.38B | 17.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.